NCT00357422 Comparison Study of Operation and PEIT for Small, Solitary Hepatocellular Carcinoma (HCC) Status COMPLETED Phase NA
NCT00355862 Immunosuppression in Patients Undergoing Liver Transplantation for Hepatocellular Carcinoma Status COMPLETED Phase PHASE3
NCT00351195 Etoposide, Oxaliplatin and Capecitabine in Advanced Hepatocellular Carcinoma (HCC) Status TERMINATED Phase PHASE2
NCT00322361 Modified Process Hepatitis B Vaccine in Healthy Neonates (V232-056) Status COMPLETED Phase PHASE2
NCT00319683 A Study of ADH300004 and 5-Fluorouracil in Locally Advanced, Recurrent, or Metastatic Hepatocellular Carcinoma Status TERMINATED Phase PHASE1/PHASE2
NCT00300521 Liver Transplantation With ADV-TK Gene Therapy Improves Survival in Patients With Advanced Hepatocellular Carcinoma Status COMPLETED Phase PHASE2
NCT00290316 Accuracy of Endoscopic Ultrasound for Detection of Tumors of the Liver Status UNKNOWN Phase PHASE2
NCT00287222 Bevacizumab and Erlotinib in Inoperable and Metastatic Hepatocellular Carcinoma Status COMPLETED Phase PHASE2
NCT00280007 Transarterial Chemoembolisation Plus Bevacizumab for Treatment of Hepatocellular Carcinoma Status TERMINATED Phase PHASE2
NCT00273312 Patupilone Activity in Advanced/Metastatic Hepatocellular Carcinoma Status COMPLETED Phase PHASE2
NCT00273247 Treatment With IFN After Curative Resection of HCC in HCV-Related Cirrhosis Status COMPLETED Phase PHASE3
NCT00242502 Efficacy and Safety Study of Bevacizumab and Erlotinib to Treat Primary Liver Cancer That Cannot be Removed By Surgery Status COMPLETED Phase PHASE2
NCT00234182 Postoperative Adjuvant Therapy With Recombinant Interferon-Alpha Following Curative Resection of HCC Status COMPLETED Phase PHASE1/PHASE2
NCT00183885 A Phase II Study of Intra-arterial Chemotherapy With Cisplatin and Mitomycin-C in Patients With Hepatocellular Carcinoma Status COMPLETED Phase PHASE2
NCT00168987 Influence of an Oral Nutritional Supplement Rich in Omega-3 Fatty Acids on Functional State and Quality of Life in Malnourished Patients With Gastroenterological Tumors Status COMPLETED Phase PHASE4
NCT00165633 A Phase II/III Clinical Study on Inhibitory Effects of E0167 on Recurrence of Hepatocellular Carcinoma Status TERMINATED Phase PHASE2/PHASE3